Announced Thu, 16 Jul · 12:47 IST
Board meeting on July 23, 2026 to consider Q1 FY27 financial results
Results View source PDF
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.8%1-day move
₹530.00
prior close
₹529.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1-0.2—-0.1-2.8+4.7+5.7+5.3+2.8+10.0————
Up moveDown movePending
AI summary
Thyrocare Technologies has scheduled a board meeting on Thursday, July 23, 2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (Q1 FY27). The trading window for designated persons and their immediate relatives has been closed from July 01, 2026 and will reopen 48 hours after the results are declared. Filed under Regulation 29 of the SEBI Listing Regulations.
Likely market impact
Routine board meeting intimation. No price impact expected until Q1 results are declared on July 23, 2026.